Technology
ESC 2026: Biomarker indicates coronary inflammation from non-contrast CT
Caristo's FAI biomarker has demonstrated capability in assessing coronary inflammation using non-contrast CT scans and predicting cardiovascular death, according to data presented at ESC 2026. The biomarker works with existing imaging infrastructure without requiring contrast agents, potentially simplifying workflow for risk stratification in coronary artery disease assessment.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network